Abstract
Familial Mediterranean fever (FMF) is a recessively inherited inflammatory disorder, characterized by recurrent attacks of fever and polyserositis. It has been considered that miscellaneous cytokines take part in the pathogenesis of the disease. The aim of this study was to investigate serum levels of soluble interleukin-2 receptor (sIL-2R), interleukin-6 (IL-6), and interleukin-10 (IL-10) in patients with FMF. The study included 42 patients with FMF (3 females, 39 males, mean age: 24.43 years) and 20 healthy volunteers as the control group (18 males, 2 females, mean age: 23.2 years). The patients were chosen according to Eliakim criteria. After recording their history and performing an examination, leukocyte counts, erythrocyte sedimentation rates (ESR), C-reactive protein (CRP), fibrinogen, sIL-2R, IL-6, and IL-10 levels were measured before and during attacks. A significant increase was found in leukocyte (p<0.001), ESR (p<0.001), CRP (p<0.001), and fibrinogen (p<0.001) levels of the patient group in the attack period compared to those in the quiescent state. sIL-2R (p=0.019) and IL-6 (p<0.001) levels showed significant increases during attacks compared to the levels before an attack. There was no significant difference between IL-10 levels. The levels of the three cytokines were significantly high both before and during the attacks compared to the control group. As a result, the elevation of sIL-2R and IL-6 levels both before and during the attacks compared to control group suggests the existence of continuous cytokine activation in the patients. No significant increase in the IL-10 levels in spite of the significant rise of sIL-2R and IL-6 during attacks supports the notion of inflammation and also reveals that compensation by anti-inflammatory IL-10 does not seem to occur.
Similar content being viewed by others
References
Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43:227–253
Schattner A, Lachmi M, Livneh A, Pras M, Hahn T (1991) Tumor necrosis factor in familial Mediterranean fever. Am J Med 90:434–438
Erken E, Günesacar R, Ozbek S, Konca K (1996) Serum soluble interleukin-2 receptor levels in familial Mediterranean fever. Ann Rheum Dis 55:852–855
Ozyılkan E, Simsek H, Telatar H (1992) Tumor necrosis factor in familial Mediterranean fever. Am J Med 92:579–580
Rozenbaum M, Katz R, Rozner I, Pollack S (1992) Decreased interleukin 1 activity released from circulating monocytes of patients with familial Mediterranean fever during in vitro stimulation by lipopolysaccharide. J Rheumatol 19:416–418
Notarnicola C, Didelot MN, Seguret F, Demaille J, Touitou I (2002) Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun 3:43–45
Mege JL, Dilşen N, Sanguedolce V, et al. (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet’s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20:1544–1549
Kishimoto T (1989) The biology of interleukin-6. Blood 74:1-10
Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165–190
Eliakim M, Levy M, Ehrenfeld M (1981) Recurrent polyserositis (familial Mediterranean fever, periodic disease). Elsevier/North-Holland Biomedical Press, Amsterdam
International Committee for Standardization in Haematology (1988) Guidelines on selection of laboratory tests for monitoring the acute phase response. J Clin Pathol 41:1203–1212
Whicher JT, Bell AM, Southall PJ (1981) Measurements in clinical management. Diagn Med 4:62–80
Ilfeld D, Weil S, Kuperman O (1981) Immunoregulatory abnormalities in familial Mediterranean fever. Clin Immunol Immunopathol 18:261–267
Melamed A, Cabili S, Zakuth V, Spirer Z (1988) The immune regulation in familial Mediterranean fever (FMF). J Clin Lab Immunol 26:125–128
Campen DH, Horwitz DA, Quismorio FP Jr, Ehresmann GR, Martin WJ (1988) Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum 31:1358–1364
Wolf RE, Brelsford WG (1988) Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 31:729–735
Keystone EC, Snow KM, Bombardier C, Chang CH, Nelson DL, Rubin LA (1988) Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum 31:844–849
Rubin LA (1990) The soluble interleukin-2 receptor in rheumatic disease. Arthritis Rheum 33:1145–1148
Oppenheim JJ, Ruscetti FW, Faltynek C (1994) Cytokines. In: Stites P, Terr AI, Parslow TG (eds) Basic and clinical immunology, 8th edn. Appleton and Lange, Northwalk, pp 105–123
Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW (1994) Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113–118
Drenth JPH, van Deuren M, van der Ven-Jongekrijg J, Schalkwijk CG, van der Meer JWM (1995) Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 85:3586–3593
Gang N, Drenth JPH, Langevitz P, Zemer D, Brezniak N, Pras M, van der Meer JWM, Livneh A (1999) Activation of the cytokine network in familial Mediterranean fever. J Rheum 26:890–897
Kiraz S, Ertenli I, Arici M, Calguneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S (1988) Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever. Clin Exp Rheumatol 16:721–724
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bagci, S., Toy, B., Tuzun, A. et al. Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 23, 333–337 (2004). https://doi.org/10.1007/s10067-004-0925-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-004-0925-4